New combo therapy aims to shrink rectal tumors without radiation
NCT ID NCT06688786
Summary
This study is testing a new treatment approach for advanced rectal cancer that avoids radiation. It combines two chemotherapy drugs with an immunotherapy drug before surgery, aiming to shrink the tumor effectively while reducing side effects that can harm long-term anal function. The goal is to see if this radiation-free method can control the disease well and improve patients' quality of life after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.